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Genetic interactionsThe ﬁne-tuning of BMP signals is critical for many aspects of complex organogenesis. In this report, we show
that the augmentation of BMP signaling by a BMP-binding secreted factor, Crossveinless2 (Cv2), is essential
for the early embryonic development of mammalian nephrons. In the Cv2-null mouse, the number of cap
condensates (clusters of nephron progenitors, which normally express Cv2) was decreased, and the
condensate cells exhibited a reduced level of aggregation. In these Cv2–/– condensates, the level of
phosphorylated Smad1 (pSmad1) was substantially lowered. The loss of a Bmp7 allele in the Cv2–/– mouse
enhanced the cap condensate defects and further decreased the level of pSmad1 in this tissue. These
observations indicated that Cv2 has a pro-BMP function in early nephrogenesis. Interestingly, the renal
defects of the Cv2–/– mutant were totally suppressed by a null mutation of Twisted gastrulation (Tsg), which
encodes another BMP-binding factor, showing that Cv2 exerts its pro-BMP nephrogenic function Tsg-
dependently. By using an embryonic kidney cell line, we presented experimental evidence showing that Cv2
enhances pro-BMP activity of Tsg. These ﬁndings revealed the molecular hierarchy between extracellular
modiﬁers that orchestrate local BMP signal peaks in the organogenetic microenvironment.
© 2009 Elsevier Inc. All rights reserved.Introduction
In terrestrial amniotes, the kidney is an indispensable and complex
organ that maintains ﬂuid homeostasis and blood pressure. Its anlage
is a tissue called the metanephros. In the mouse, metanephric
development starts about embryonic day (E) 10.5 with the demar-
cation of the metanephric blastema in the caudal part of the
intermediate mesoderm, followed by reciprocal inductions between
the blastema and the Wolfﬁan duct (Vainio and Lin, 2002). In
response to metanephric blastema-derived signals, the ureteric bud
forms from the Wolfﬁan duct, invades the metanephric blastema, and
successively branches to form the collecting ducts. Conversely,
ureteric bud-derived signals induce the formation of metanephric
blastema-derived condensates (cap condensates) around the tips of
collecting ducts; the cells forming the condensates will ultimately give
rise to the nephrons, which carry out the functions of the adult kidney
(Kobayashi et al., 2008). Although the signaling networks thatoshikisasai@cdb.riken.jp
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ll rights reserved.regulate duct branching have been extensively studied (Shah et al.,
2004), relatively little is known about the molecular mechanism of
how cap condensates are formed and maintained (Kobayashi et al.,
2008; Oxburgh et al., 2004).
The Bone Morphogenetic Protein (BMP) family is a class of
secreted signaling proteins that belong to the transforming growth
factor-beta (TGFβ) superfamily; they have diverse effects on the
control of embryogenesis, including kidney development (Cain et al.,
2008; Godin et al., 1998; Hogan, 1996; Simic and Vukicevic, 2005). An
intriguing feature of BMP signaling is the presence of various
extracellular BMP inhibitors (i.e., anti-BMP factors), such as Chordin,
Noggin, Follistatin, Cerberus, and Gremlin (Glinka et al., 1997;
Hemmati-Brivanlou et al., 1994; Hsu et al., 1998; Lamb et al., 1993;
Sasai et al., 1995, 1994; Smith and Harland, 1992). Moreover, recent
studies show that there are some proteins that bind to BMPs
extracellularly and augment their signaling (i.e., pro-BMP factors).
One protein with pro-BMP functions is Crossveinless2 (Cv2; also
called Bmper), which enhances BMP signaling during wing cross-vein
formation in Drosophila, as well as in neural crest emigration in the
chick embryo, dorsal-ventral patterning of the zebraﬁsh gastrula, and
some cultured cell lines (Coles et al., 2004; Conley et al., 2000;
Kamimura et al., 2004; Kelley et al., 2009; Moser et al., 2007; Rentzsch
et al., 2006; Serpe et al., 2008).
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role in various in vitro and in vivo contexts (Ambrosio et al., 2008;
Binnerts et al., 2004; Coles et al., 2004; Harada et al., 2008; Kelley
et al., 2009; Moser et al., 2003; Rentzsch et al., 2006; Zhang et al.,
2007, 2008). For instance, Cv2 exerts both pro- and anti-BMP
activities when injected into the zebraﬁsh embryo (Rentzsch et al.,
2006). In the Xenopus gastrula, Cv2 acts predominantly as an anti-
BMP factor (Ambrosio et al., 2008). While endocytic internalization is
proposed to contribute to Cv2's anti-BMP activity, this machinery
appears to be restricted to a limited range of cell types (Kelley et al.,
2009). Biochemical and crystal structure analyses suggest that
vertebrate Cv2 may interfere with BMP ligand-receptor binding via
its Chordin-type cysteine-rich domain (CR1; Zhang et al., 2007; Zhang
et al., 2008), although the in vivo relevance of such molecular
interactions remains elusive. More recently, Cv2 was shown to bind
other proteins, such as Chordin (Ambrosio et al., 2008), suggesting
that Cv2's function is complex, and its role as a pro- or anti-BMP factor
may be context-dependent. Therefore, careful investigation is re-
quired to identify the in vivo role of Cv2 in different developmental
contexts.
Previously, by showing a genetic enhancement between Bmp4 and
Cv2, we demonstrated that Cv2 functions as a pro-BMP factor in
vertebral and eye development (Ikeya et al., 2006). In the same study,
we found kidney defects (hypoplasia) in Cv2-null mouse embryos.
Our previous report showed that Cv2 acts in the same direction with
Kcp, which functions as a pro-BMP factor in a different context (Ikeya
et al., 2006; Lin et al., 2005). However, our previous study could not
tell whether Cv2 in the developing kidney was required as a pro- or
anti-Bmp factor, because of the lack of genetic evidences showing
functional interaction between Cv2 and Bmp ligands.
Here, we report that Cv2 plays an essential role as a pro-BMP factor
in mouse kidney development.We found that Cv2 promotes the BMP-
dependent formation of the cap condensates, and we present genetic
evidence that the pro-BMP function of Cv2 is dependent on the
presence of Tsg, another BMP modulator. These results demonstrate
that an extracellular system for modulating local BMP signals via
Cv2 and Tsg plays a key role in the early steps of mouse nephron
development.
Materials and methods
Mutant mice and crosses
Mice carrying mutations in Cv2, Bmp7, Tsg, and Smad1 were
described previously (Hayashi et al., 2002; Ikeya et al., 2006; Luo et al.,
1995; Nosaka et al., 2003). We crossed Cv2+/– mice with Bmp7+/–,
Tsg–/– or Smad1+/– mice to obtain compound heterozygotes. No
obvious defects were observed in the compound heterozygotes, and
we used them for further intercrosses. Genotypes were conﬁrmed by
PCR (Ikeya et al., 2006, 2008). Animals were housed in environmen-
tally controlled rooms in accordance with RIKEN guidelines for animal
experiments.
LacZ staining, histology, immunohistochemistry, and statistics
LacZ staining, histology, and immunohistochemistry were per-
formed as described previously (Ikeya et al., 2006). Primary
antibodies and dilutions were as follows: anti-alpha-catenin, 1:500
(Sigma, rabbit polyclonal); anti-BF2, 1:500 (Abcam, goat polyclonal);
anti-cadherin-11, 1:500 (R&D, goat polyclonal); anti-Cv2, 1:1000
(R&D, goat polyclonal); anti-E-cadherin, 1:500 (Takara, ECCD2); anti-
β-galactosidase, 1:5000 (Cappel, rabbit polyclonal) or 1:2000 (AbD
Serotec, goat polyclonal); anti-laminin, 1:500 (Chemicon, AL-4); anti-
NCAM, 1:1000 (Chemicon, rabbit polyclonal); anti-Pax2, 1:200
(Zymed, rabbit polyclonal); anti-phospho-Smad1/5/8, 1:30 (Cell
Signaling, rabbit polyclonal); and anti-WT1, 1:50 (Santa Cruz, rabbitpolyclonal). For staining with the anti-WT1 antibody, citrate buffer,
pH 6, was used for antigen retrieval (Zymed) in a 2100 Retriever
(PickCell Laboratories). The anti-Cv2 polyclonal antibody recognizes
both N- and C-halves of cleaved Cv2 (data not shown).
The signal intensity of the phospho-Smad1/5/8 staining was
compared as follows, using the ImageJ software (National Institutes of
Health, Bethesda, MD). We stained sections with phospho-Smad1/5/
8-speciﬁc antibody and DAPI and acquired images by scanning the
sections with a confocal microscope (LSM510 (Zeiss)). The images
were trimmed into smaller ones showing either cap condensates or
collecting ducts, and we divided the total signal intensity of phospho-
Smad1/5/8 in the trimmed regions by DAPI-positive area. We deﬁned
this value as the “average signal intensity” of phospho-Smad1/5/
8 and compared it across images. No differences were observed
among the average signal intensities of the collecting ducts, regardless
of the genotype. We regarded average signal intensities from cap
condensates that were less than two thirds of the collecting duct
average intensity as “reduced.”
The numbers of nephrons and nephron progenitors at E18.5 were
counted as described previously (Ikeya et al., 2006). We scored eight
to 20 embryos of each genotype to obtain these numbers. The number
of LacZ-positive cap condensates at E13.5, 14.5, and 15.5 was obtained
from six to 30 kidneys from each genotype.
Statistical analyses were performed using GraphPad Prism 4
(GraphPad Software).
Cell culture, transfection, siRNA, and luciferase assay
HEK293T cells were maintained in DMEM/10% FCS (HyClone). To
examine the effect of Cv2 on BMP signaling, reverse transfections
were performed in a 24-well cell culture plate (BD Falcon) using
FuGene6 (Roche, Basel, Switzerland) with a total of 210 ng DNA [ 100
ng of BRE-luc (Korchynskyi and ten Dijke, 2002), 10 ng of phRL-null
(Promega), and the indicated dose of CIG-mCv2 and CIG-LacZ
(Megason andMcMahon, 2002)] per well, in DMEM/1% FCS. Annealed
and puriﬁed siRNA duplexes were obtained from Ambion (Austin, TX)
and were added at 75 ng per well 4 h prior to the cDNA transfection
with X-treme Gene (Roche, Basel, Switzerland). After 16 h of
treatment, the cells were lysed and assayed for luciferase activity
using the dual luciferase reporter assay system (Promega, Madison,
WI), according to the manufacturer's instructions.
Results
Enhancement of hypoplastic phenotypes in the Cv2–/– kidney by
Bmp7+/– mutation
We previously demonstrated that Cv2-null mice display a reduced
kidney size and lower nephron number than wild-type mice (Ikeya
et al., 2006). To examine the role of Cv2 during nephrogenesis, we ﬁrst
analyzed Cv2's expression patterns during kidney development in
nLacZ-knock-inmice (Cv2+/nLacZ). At E11.5, themetanephric blastema
expressed Cv2nLacZ, whereas the ureteric buds were negative for it
(Figs. 1A–C). At E12.0, the maturating stromal cells located in the
central portion of the kidney became Cv2nLacZ-negative (asterisk in
Fig. 1D). At E13.5 and E14.5, the Cv2nLacZ expression was mainly
restricted to the cap condensates (Figs. 1E–H, and data not shown)
and to portions of the forming nephrons (pretubular aggregates,
comma-shaped body, and S-shaped body) and Bowman's capsules
(Supplementary Figs. S1A–D). Immunohistochemical analyses con-
ﬁrmed that cap condensate cells positive for Pax2 strongly expressed
Cv2nLacZ, but the peripheral stroma, which was positive for BF2, and
collecting ducts did not (Supplementary Figs. S2A–C). From E14 until
birth, the Cv2nLacZ expression was restricted to the cap condensates
and its derivatives (data not shown).
Fig. 1. Cooperative roles of Cv2 and Bmp7 in kidney development. (A–G) Expression of Cv2 analyzed with nLacZ knock-in mice. (A–C) At E11.5, LacZ staining was observed in the
trigeminal ganglion (tg), optic cup (oc), otic vesicle (ov), sclerotome (sc), roof plate of the neural tube (triangles), and metanephric blastema (mb), but not in the ureteric bud
(ub). (D) At E12.0, the central portion of the metanephric mesenchyme became Cv2nLacZ negative (asterisk). cd, collecting duct; cc, cap condensates. (E–G) At E14.5, Cv2nLacZ was
preferentially expressed in the cap condensates (bracket in G) and the ureteric mesenchyme (um). Triangles in (G) indicate that the peripheral stroma (ps) was Cv2nLacZ-negative.
(H) Schematic representation of the cortical region of the embryonic kidney. pa, pretubular aggregate. (I–L) External appearances of the control, Cv2–/–, Bmp7+/–;Cv2–/–, and
Bmp7–/– kidneys at E18.5. (M) Length of the long axis. (N–Q) Longitudinal sections stained with hematoxylin and eosin at E18.5. (R) The number of nephrons in the maximal
longitudinal sections. (S–V) External views at E14.5 stained with Cv2nLacZ. (W, X) The number of Cv2nLacZ-positive cap condensates at E14.5 (W, Tukey test), and E13.5 and E15.5
(X, Bonferroni test). Error bars show S.D.; n.s., no signiﬁcant difference; ⁎⁎⁎Pb0.001; ⁎⁎Pb0.01; ⁎Pb0.05. In (R) and (W), statistical analyses of the Bmp7–/– samples were
performed separately because of signiﬁcant differences among the S.D.s.
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notypes, suggest a crucial role for Cv2 in nephrogenesis, the molecular
mechanism of Cv2's action, and particularly whether it functioned as a
pro-BMP or anti-BMP factor in this developmental context, was
unclear. Among the Bmp genes, Bmp7 is strongly expressed in the cap
condensate, as well as in the ureteric bud, collecting duct, and forming
nephron (Supplementary Fig. S3A;Dudley andRobertson, 1997;Godin
et al., 1998), and its mutation causes progressive renal hypoplasia
(Dudley et al., 1995; Luo et al., 1995). In addition, Cv2 binds BMP7with
a high afﬁnity (Zhang et al., 2007). These ﬁndings suggested that Cv2
might interactwith BMP7 in kidney development.We therefore tested
their functional interaction by crossing Cv2 mutants with Bmp7
mutants (Figs. 1I–X).
At E18.5, the loss of one allele of Bmp7 in the Cv2+/+ or Cv2+/–
background had no obvious effects on kidney development (Figs. 1M,
R, lanes 1–4). Similarly, the loss of one Cv2 allele in the Bmp7–/–
background had little effect on kidney size or nephron number
(Figs. 1M, R, lanes 7, 8). In contrast, the deletion of a single Bmp7 allele
in the Cv2–/– background caused further reductions in the kidney size
and nephron number at E18.5 than seen in Cv2–/– mice at the same
age (Figs. 1J, K, O, P; Figs. 1M, R, lanes 5, 6).
A similar genetically enhanced reduction in the number of cap
condensates (marked by the expression of Cv2nLacZ) was evident
during the early stages of kidney development, even at E14.5 and
E15.5 (Figs. 1S–X). In addition, the enhanced decrease in the
components of the forming nephrons (comma- and S-shaped bodies)
was obvious in the Bmp7+/–;Cv2–/– kidney, particularly at E15.5
(Fig. 1X and Supplementary Fig. S4).
These observations support the idea that Cv2 plays a pro-BMP role
in the early phases of nephron formation.Fig. 2. Distribution of the Cv2 protein. Cv2 protein was accumulated in both the pericellular
Immunohistochemistry with anti-Cv2 antibody at E12.5. Arrowheads, accumulation of Cv2
was observed in the pericellular region of the Cv2nLacZ-positive cells (arrows in G–I) and the
in the Cv2–/– mutants. Punctate pericellular signals co-localized with ﬁbronectin (FN; arrowCv2 is essential for high levels of BMP signaling in cap condensates
These ﬁndings prompted us to study the expression and functions
of Cv2 proteins in the early embryonic kidney. To this end, we
performed immunohistochemical analysis of Cv2 protein in the
developing kidney (Fig. 2). At E12.5 and E14.5, the Cv2 protein had
accumulated in two regions: the pericellular region of the Cv2nLacZ-
expressing cap condensates (punctate signals; arrows in Figs. 2G–I)
and the basement membrane of the collecting ducts (continuous
signals; arrowheads in Figs. 2B, E). No immunostaining was observed
in the Cv2–/– kidney, demonstrating the speciﬁcity of the antibody
(Fig. 2F). Both the pericellular and the basement membrane signals
co-localized with ﬁbronectin (Figs. 2G–I) and laminin (data not
shown), suggesting that Cv2 protein is densely accumulated in the
extracellular matrix. This ﬁnding is in accordance with the previous
work demonstrating Cv2's co-localization with extracellular matrix
(Rentzsch et al., 2006; Serpe et al., 2008).
To identify the site of action of Cv2 in renal development, we next
analyzed the levels of intracellular BMP signaling in wild-type and
mutantmice by detecting a downstream component of BMP signaling,
phosphorylated Smad1/5/8 (pSmad1), which is frequently used to
assay BMP activity. At E14.5, high pSmad1 signals were observed in
both the cap condensates (cc) and the tips of the collecting ducts (cd)
in wild-type and Bmp7+/– embryos (Fig. 3A and Supplementary
Fig. S5). In contrast, in Cv2–/–, Bmp7+/–;Cv2–/–, and Bmp7–/– embryos,
pSmad1 staining was reduced in the cap condensates, whereas no
substantial change was observed in the collecting ducts (Figs. 3B–D).
Fig. 3I shows the percentages of cap condensates with reduced
pSmad1 signals (in this analysis, signal levels comparable to those in
the collecting duct cells were considered to be high). As shownregion of the cap condensate and the basement membrane of the collecting duct. (A–C)
on the surface of the collecting duct and ureteric bud. (D–I) At E14.5, anti-Cv2 staining
basement membrane of the collecting duct (arrowhead in E). (F) No signal was detected
s in G–I).
Fig. 3. A pro-BMP role of Cv2 in the cap condensates but not in the collecting ducts. Staining intensity of pSmad1 was decreased in cap condensates of Cv2–/–, Bmp7+/–;Cv2–/–, and
Bmp7–/– kidneys, but it was unchanged in the collecting ducts from all genotypes. Blue, DAPI; red, phospho-Smad1/5/8 (pSmad1)-speciﬁc antibody. (I) Percentages of cap
condensates showing reduced pSmad1 signal intensity. Under the Cv2–/– background, the Bmp7+/+ and Bmp7+/– groups exhibited a signiﬁcant differences (P value=0.0007) by
Chi-square test.
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enhanced the reduction of pSmad1 in the Cv2–/– background,
suggesting that Cv2 acts in the same direction as BMP7 (i.e., as a
pro-BMP factor).
These observations indicate that Cv2 is essential for enhancing
BMP signals in the cap condensate during kidney organogenesis, but
that the high BMP signals in the collecting ducts are independent of
Cv2, suggesting a tissue-speciﬁc mode of Cv2's action.
Incomplete cellular aggregation in the Cv2–/– cap condensates
During nephrogenesis, cap condensates are formed as compact cell
aggregates at the tips of the collecting ducts (cc in Fig. 4A). As shown
above, BMP signaling was attenuated in the cap condensates of Cv2–/–
and Bmp7+/–;Cv2–/– mutants. In addition, thin section analysis
revealed impaired cell–cell attachment in the Cv2–/– and Bmp7+/–;
Cv2–/– cap condensates (see loosely packed aggregates in Figs. 4B, C;
E14.5), although the cells looked healthy and did not exhibit signs of
apoptosis such as picnosis. These observations indicate that the loss of
Cv2's pro-BMP function not only reduced the cap condensate number
but also caused abnormal cellular aggregation.
Next, we further examined the cellular aggregation by immunos-
taining. While adhesion molecules such as NCAM and cadherin11
(also alpha-catenin) were distributed uniformly in the cell–cellinterface regions in the cap condensate of control embryos (Figs. 4E,
I, M), these protein appeared discontinuous or punctate in the Cv2–/–
and Bmp7+/–;Cv2–/– mutants (arrowheads in Figs. 4F, G, J, K, N, O).
These changes did not seem to be caused by a loss of speciﬁc cell types,
since the cell type-speciﬁc markers (Pax2 and p75 for the cap
condensate and BF2 for the peripheral stroma) were expressed
normally in thesemice (Figs. 4Q–S, and data not shown). Rather, these
results indicate that a local augmentation of BMP signaling by Cv2 is
crucial for the proper formation of cap condensates, including the
cap–cell aggregation, during kidney development.
To focus in on which developmental step was most dependent on
Cv2, we investigated the marker expression and aggregation of the
cap cells in the Bmp7–/– kidney. We found, as reported previously,
that the number of Pax2+ cells in the Bmp7–/– cap condensates was
severely reduced (Fig. 4T; Dudley et al., 1995; Luo et al., 1995). The
adhesion molecules were found in a discontinuous pattern (Figs. 4H,
L, P), resembling those in the Cv2 mutants. In addition, the
morphology of Bmp7–/– cap condensates were substantially impaired
(evenmore drastically than Cv2–/– and Bmp7+/–;Cv2–/– condensates),
consisting of cells with a generally round shape (Fig. 4D). These
results imply that the complete loss of BMP7 signaling affected the cap
condensate in terms of both the cellular presence (Pax2 expression; as
reported previously (Dudley et al., 1995; Dudley and Robertson, 1997;
Luo et al., 1995)) and the formation of the aggregates. In contrast, the
Fig. 4. Cv2 required for the cellular aggregation of the cap condensates. (A–D) Plastic thin sections stainedwith toluidine blue. In Cv2–/– and Bmp7+/–;Cv2–/– kidneys, cap condensate
cells adhered loosely to one another. In the Bmp7–/– kidney, the cells on the tip of the collecting duct became round. (E–P) Disturbed distribution of adhesion proteins in the cap
condensates of the mutants. Immunohistochemistry with (E–H) anti-NCAM, (I–L) anti-cadherin11, and (M–P) anti-alpha-catenin. (Q–T) Immunohistochemistry with anti-Pax2
(green) and anti-BF2 (red). The Pax2-positive cap condensates and collecting ducts and the BF2-positive peripheral stroma developed normally in the Cv2–/– and Bmp7+/–;Cv2–/–
mutants. In the Bmp7–/– kidney, the number of Pax2-positive cells was markedly reduced.
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impaired the formation of the cellular aggregates.
Tsg mutation is epistatic to the Cv2 mutation in the
kidney-defect phenotype
Taken together, our genetic and histochemical analyses demon-
strated that Cv2 is an essential pro-BMP factor for the development of
cap condensates in the early embryonic kidney. An obvious remaining
question is how Cv2 promotes BMP signaling in these cells.
Very recently, two independent studies (from De Robertis' and our
groups) reported a genetic interaction between Cv2 and Tsg in
skeletal development (Ikeya et al., 2008; Zakin et al., 2008). Themajorskeletal defects of the Cv2-null mutant mice (in the thoracic and
lumbar vertebrae) are suppressed in Tsg–/–;Cv2–/– embryos, which
showmoderate skeletal phenotypes (Nosaka et al., 2003; Petryk et al.,
2004; Zakin and De Robertis, 2004). This suggests that the Tsg
mutation is epistatic to the Cv2 mutation in skeletal development.
However, the precise molecular and cellular mechanism of this gene
interaction in embryonic development was still unknown.
With this in mind, we examined possible interactions between Cv2
and Tsg in kidney development (Tsg expression is detected diffusely in
the developing kidney (Supplementary Fig. S3B; Nosaka et al., 2003)).
In nephrogenesis, as opposed to skeletal development, interactions
with the Tsgmutation can be analyzed rather simply, because the Tsg
mutation itself does not cause signiﬁcant embryonic kidney
Fig. 5. Evidence for a Tsg-dependent pro-BMP function of Cv2 in vivo. Renal phenotypes of Cv2–/– rescued by the deletion of both alleles of Tsg at E18.5 and E14.5. (A–E) External
views at E18.5. (F) Length of the long axis. (G–K) Histological sections at E18.5. (L) The number of nephrons in themaximal longitudinal sections. (M–P) Immunohistochemistry with
anti-pSmad1 at E14.5. (Q) Percentages of cap condensates exhibiting reduced pSmad1 signal intensity. (R–U) Immunohistochemistry with anti-NCAM at E14.5. Error bars show S.D.;
n.s., no signiﬁcant difference; ⁎⁎⁎Pb0.001; ⁎⁎Pb0.01; ⁎Pb0.05 (Bonferroni test).
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backgrounds, the loss of both Tsg alleles did not signiﬁcantly affect
kidney size or nephron number at E18.5 (Figs. 5A, B, G, H; Figs. 5F, L,
lanes 1–6). In contrast, when combined with the Cv2–/– mutation, the
elimination of Tsg completely suppressed the renal defects otherwise
present in Cv2-null mutants (Figs. 5C–E, I–K; Figs. 5F, L, lanes 1, 7–9).
The Tsg deletion also restored the levels of BMP signaling (reduced
pSmad1 levels) in the cap condensates of Cv2-null mutants at E14.5
(Figs. 5M–Q) and rescued the impaired cell–cell adhesion in the
condensates (Figs. 5R–U).
These in vivo ﬁndings suggest a unidirectional dependence in
which the pro-BMP function of Tsg requires Cv2, while Cv2 function is
not dependent on Tsg activity.
Tsg-dependent mechanism of Cv2's pro-BMP function in cultured
embryonic kidney cells
The suppression of the Cv2–/– kidney phenotypes by the Tsg
mutation implied that, as a whole, Cv2 and Tsg act in opposite
directions. That is, they appeared to play pro-BMP and anti-BMP roles,
respectively, during nephrogenesis. Interestingly, previous studies
suggested that Tsg can act as an anti-BMP or pro-BMP factor,
depending on the context (Chang et al., 2001; Harland, 2001; Larrain
et al., 2001; Oelgeschlager et al., 2000; Ross et al., 2001; Scott et al.,
2001). For instance, genetic interaction studies of mouse Tsg-null
mutations with Bmp4 and Bmp7 mutations show Tsg acting as a pro-
BMP factor in head development and posterior mesodermal pattern-
ing (Zakin and De Robertis, 2004; Zakin et al., 2005). In Xenopusembryos, the Chordin–Tsg complex binds to BMPs and inhibits their
signaling more efﬁciently than Chordin, an anti-BMP factor, does
alone (anti-BMP activity of Tsg; Oelgeschlager et al., 2000; Scott et
al., 2001). In the presence of the Chordin-degrading enzyme Xolloid,
on the other hand, Tsg dislodges BMP from cleaved Chordin
fragments, resulting in enhanced BMP signaling (a pro-BMP activity;
Oelgeschlager et al., 2000).
Given the context-dependent bidirectional functions of Tsg and our
ﬁndings in this study, the following hypothetical models could explain
the functional interaction between Cv2 and Tsg in nephrogenesis. (1)
The pro-BMP factor Cv2 and the anti-BMP factor Tsg act independently
on BMP signals as simple antagonists (Fig. 6A,Model a). (2) Cv2 acts as
a pro-BMP factor by interfering with the anti-BMP function of Tsg
(Fig. 6A, Model b). (3) Tsg has simultaneous dual functions as both a
pro-BMP and an anti-BMP factor, while Cv2 acts as a co-factor to
strengthen the pro-BMP aspect of Tsg's functions (Fig. 6A, Model c).
Given that the ﬁne-tuning of BMP signals is vital for kidney
organogenesis (Cain et al., 2008), the phenotypical discrepancy
between the normal kidney development of Tsg–/– embryos and the
marked hypoplasia of Cv2-null embryos is rather difﬁcult to explain
with hypothetical Models a and b, which predict hyperactive BMP
levels in Tsg–/– kidneys. In contrast, the BMP activity level under the
Tsg–/– condition would be less affected in the hypothetical Model c,
in which the simultaneous loss of both the anti- and pro-BMP
functions could reduce the extent of change in signaling strength
(Supplementary Fig. S6B). Consistent with this idea, we have not
seen substantial changes in pSmad1 levels in Tsg–/– embryonic
kidneys compared with control kidneys (Fig. 5N and our preliminary
Fig. 6. Cv2 enhances pro-BMP activity of Tsg in HEK293T cell. (A) Models of the interaction between Tsg and Cv2. (B) Knockdown efﬁciency of Tsg mRNA. Expression levels were
determined by quantitative real-time PCR analysis. (C) siRNA targeting of Tsg attenuates BMP signaling. Error bars show S.D.; ⁎⁎Pb0.01 (Dunnet test). (D) Dose-dependent activation
of BMP signaling by Cv2 in HEK293T cells. (E) siRNA targeting of Tsg reduces dose-dependent activation of BMP signaling by Cv2. (F) Tsg knockdown cells respond normally to
treatment with high levels BMP4.
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type, at least in this respect.
To test the predictive ability of this model, one essential question is
whether Cv2 can in fact function as a co-factor for the pro-BMP
activity of Tsg in kidney development. This question is particularly
relevant in light of a Xenopus study that suggests that Cv2 enhances
the anti-BMP activity of Tsg in a different developmental context
(dorsal-ventral patterning during gastrulation) (Ambrosio et al.,
2008). Therefore, we next examined whether Cv2 promotes BMP
signaling under the condition in which Tsg predominantly exerts a
pro-BMP activity over an anti-BMP function.
In a series of preliminary experiments, we found that a human
embryonic kidney-derived cell line, HEK293T, expresses Tsg as well
as Cv2 and BMPs (Supplementary Fig. S7), and that endogenous Tsg
acted predominantly as a pro-BMP factor, since, when Tsg was
knocked down by siRNAs (see Fig. 6B for the knockdown efﬁciency),
the BMP signaling reporter (BRE-luc) activity was reduced accord-
ingly (Fig. 6C). In this cell line, the expression of exogenous Cv2
(introduced by plasmid transfection) strongly augmented the BMP
signal in a dose-dependent manner, showing a pro-BMP activity
(Fig. 6D, open columns). This augmentation appeared to depend on
extracellular BMP signaling, since the addition of Noggin to the
culture medium completely suppressed it (Fig. 6D, closed columns).
Importantly, there was little augmentation of BMP signaling by Cv2 in
the Tsg-depleted HEK293T cells (Fig. 6E). This absence of the Cv2-
induced increase in the Tsg-depleted cells was not owing to a general
loss of the cellular BMP signaling pathway, because the BRE-luc
activity was strongly stimulated by high concentrations of BMP4 also
in these cells (Fig. 6F).
These data show that Cv2 functions as a pro-BMP factor in the
presence of Tsg, which has a pro-BMP role in this embryonic kidney
cell line, supporting the idea that Cv2 can enhance the pro-BMP
activity of Tsg at least under certain situations (Fig. 6A, Model c).
Discussion
In this report, we demonstrated that Cv2 plays an essential pro-
BMP role in early nephrogenesis. The cap condensate is the embryonic
kidney tissue that normally expresses Cv2, and its development wassubstantially affected by the Cv2-null mutation, even during very
early histogenesis. The loss of Cv2 directly attenuated the BMP
signaling in this tissue, as assessed by its reduced pSmad1 levels
(Fig. 3; in contrast, pSmad2 levels were largely unaffected; Supple-
mentary Fig. S8). In contrast, the Cv2 mutation did not substantially
affect the high BMP signaling levels in the neighboring collecting duct
cells, which do not normally express Cv2. Taken together, these
observations suggest that Cv2 is a local (or short-range) enhancer of
BMP signaling that mainly acts in a tissue-autonomous fashion. In
other words, the tissue augments its own BMP response by expressing
Cv2.
At least three mechanistic explanations for the context-depen-
dent pro-BMP function of Cv2 have been advocated so far: (1) a
cleaved Cv2 protein, rather than a full-length one, exerts a pro-BMP
activity (shown in a zebraﬁsh study; Rentzsch et al., 2006). (2) Cv2
is a biphasic BMP modulator acting in a dose-dependent manner
that, only at a low dose, facilitates the binding of BMPs to their type I
receptor (shown in a Drosophila study; Serpe et al., 2008). (3) Cv2
increases the local concentration of diffusible Chordin/Tsg/BMP
protein complexes (e.g., on the ventral side in the case of the Xe-
nopus embryo), which release active BMPs to their cell surface
receptors upon the cleavage of Chordin by tolloid proteinases
(proposed in a Xenopus study; Ambrosio et al., 2008). In this case,
the entrapment of BMP into the complexes is an anti-BMP process,
while the release of BMP from the accumulated Chordin/Tsg/BMP
complexes (i.e., reservoir complexes for BMP) serves as a pro-BMP
step.
Of the three proposals (which are not mutually exclusive), the last
one (Mechanism 3) ﬁts our in vivo and in vitro data particularly well.
First, our immunostaining results showed that Cv2 proteins are
associated with the pericellular matrix (Fig. 2), which could make Cv2
less diffusible. Since Cv2 can physically interact with Chordin, Tsg and
BMP (Ambrosio et al., 2008), the Cv2-bound pericellular matrix
supposedly contributes to the local accumulation of Chordin/Tsg/BMP
complexes. Second, the Cv2-null mutation speciﬁcally affected the cap
condensates, which are normally surrounded by auto/paracrine Cv2.
Third, Cv2 functions as a pro-BMP factor in the presence of Tsg, which
is evidence that Cv2 might function in a complex, as proposed for
Mechanism 3.
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(Fig. 6A), in which pro- and anti-BMP functions of Tsg can co-exist. In
this interpretation, which combines Model c and Mechanism 3, Cv2
preferentially enhances the pro-BMP activity of Tsg; this activity is
expected to depend heavily on the Cv2-mediated local high
concentration of reservoir complexes that potentially release BMP.
In contrast, the inactivation of BMPs by their entrapment in the
Chordin–Tsg complex (anti-BMP) is Cv2-independent presumably
because the entrapment process itself does not require the speciﬁc
localization of the complexes. By using an embryonic kidney cell line,
in which the pro-BMP function of Tsg is predominantly observed
(Fig. 6E), we presented the practical feasibility of Model c (Fig. 6A), at
least with respect to the cooperative pro-BMP function of Cv2 and Tsg.
Consistent with Model c and also Mechanism 3, Cv2 exerts pro-BMP
function in the presence of Tsg in this cell culture system. In the
future investigations, other models must also be ruled out, including
one in which Cv2 acts as an inhibitor of Tsg's anti-BMP activity, rather
than as a co-factor of its pro-BMP activity (a sort of fusion of Models b
and c).
This report mainly focused on the pro-BMP role of Cv2. Genetic
analyses of Bmp7;Cv2 mutants provide ﬁrm evidences that Cv2 acts
predominantly as a pro-BMP factor in early nephrogenesis. In addi-
tion, a genetic enhancement in the nephron number was observed
between Cv2 and Smad1 (Supplementary Fig. S9), indicating that Cv2
works cooperatively not only with the extracellular BMP ligand
(BMP7) but also with the major transducer of BMP receptor signaling.
Although these data do not argue the presence of a minor anti-BMP
function of Cv2, it is considered the total Cv2 activity, at least on
balance, is deviated toward the pro-BMP direction in the context of
kidney development.
This report also focused on its genetic interactions with Tsg.
Whereas it is beyond the scope of this genetics-based study, iden-
tifying the detailed molecular mechanisms underlying the pro-BMP
function at the protein level is an important topic for future
comprehensive study (Umulis et al., 2009). For instance, it will be
intriguing to show the different kinetics of BMP release from com-
plexes of Cv2 with Tsg versus Cv2 with Chordin, or the concentration
or presentation of the ligand-bearing complexes to the receptor. It is
also interesting to learn whether the role of mammalian Tsg in kidney
development in fact depends on Chordin, especially given that Chor-
din and Chordin-related genes are expressed in the embryonic kidney
(Supplementary Fig. S10). Because good antibodies for immunohis-
tochemical studies of Tsg, Chordin and the tolloids are not available
(our preliminary observations), we cannot currently examine wheth-
er Tsg–Chordin complexes are concentrated or speciﬁcally degraded
near the cap condensate. Visualizing the dynamic localization, diffu-
sion and processing of the complex proteins is a challenging but
critical future task.
Our preliminary study showed that the decrease of nephron
numbers in Cv2–/– kidneys (E14.5) was also moderately enhanced by
adding a Bmp4+/– mutation similar to that observed with Bmp7+/–
mutation (Supplementary Fig. S11). On the other hand, during late
nephrogenesis, the Bmp4+/– mutation strongly enhanced the hydro-
ureter phenotypes in the Cv2–/– kidneys (Supplementary Fig. S12). In
this case, the formation of the ureter mesenchyme, which expresses
Bmp4 but not Bmp7, was strongly inhibited, suggesting that BMP4
cooperates with Cv2 independently of BMP7, at least in this context.
Thus, whether BMP7 acts as a homodimer or a heterodimer with
BMP4 in the Cv2 interaction is a remaining question for further
investigation.Conclusion
From our in vivo and in vitro observations, we conclude that Cv2,
in concert with Tsg, shapes the signaling landscape in the complexorganogenetic microenvironment of the kidney, creating locally res-
tricted peaks in the BMP signal.
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